Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CDXS
CODEXIS, INC.
NASDAQ
$1.59
▼ DOWN 4.22% (-0.07)

KEY STATISTICS

Market Cap$171.02 M
52w High$2.98
52w Low$0.96
Dividend Yield—
Frequency—
P/E-4.68
Volume634.42K
Shares Out.107.56M

COMPANY

LEADERSHIP

Alison Moore
CHIEF EXECUTIVE
Alison Moore

COMPENSATION 2026

Salary$758,903
Stock Awards$374,954
Incentive Plan Pay$521,051
All Other Comp.$50,007
Total$2,194,601

ABOUT

SECTOR
Healthcare
WENT PUBLIC
April 22, 2010
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
146

PRICE TARGET

Target High$5.00
Target Low$5.00
Target Median$5.00
Target Consensus$5.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$18.62M
NOV
5
THU

PRICE

$1.59 ▼ DOWN 4.22% (−$0.07)
$1.59$1.62$1.65$1.689:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM1.59

About Codexis, Inc.

https://www.codexis.com ↗

Codexis, Inc. develops and sells enzymes, proteins, and biocatalysts, offering screening, engineering services, and platforms for chemical manufacturing and drug discovery, primarily serving pharmaceutical and biotech industries.

INDUSTRY

Biotechnology

A PRODUCT CODEXIS, INC. IS KNOWN FOR

ECO Synthesis™ Manufacturing Platform
ECO Synthesis™ Manufacturing Platform

A proprietary enzyme-catalyzed platform enables large-scale, sustainable, and cost-effective manufacturing of RNA therapeutics like siRNA, offering a more efficient alternative to traditional chemical synthesis to meet rising RNA drug demand.

COMPETITORS

COMPETITOR
DNA COMPARE
PGEN COMPARE
TWST COMPARE
ZYME COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product$6.81M $5.78M ▼$7.19M ▲$13.22M ▲
Research and Development Revenue$1.79M $42.88M ▲$8.06M ▼$1.7M ▼

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
APAC$6.06M — $5.33M ▼$11.74M ▲
Americas$1.57M $33.53M ▲$7.86M ▼$1.72M ▼
EMEA$972K $2M ▲$2.06M ▲$1.45M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
66
LISTED HERE
13
RANKED BY POSITION SIZE
VTI
0.00% · 3.1M
XSU.TO
0.00% · 2.3M
R2SC.L
0.01% · 200.9K
FESM
0.00% · 170.5K
XRSU.L
0.01% · 88.7K
PRFZ
0.00% · 71.3K
DFMC
0.00% · 56.7K
RSSL
0.00% · 41.1K
JF
JFWD
6.12% · 17.0K
AVSC
0.00% · 4.0K
URTY
0.00% · 3.5K
FVI
0.03% · 354
RESM
0.01% · 241

INSTITUTIONAL OWNERSHIP

SHARES OWNED
58.91%
HOLDERS
202
TOP 12 OF 202 · RANKED BY POSITION SIZE
Opaleye Management Inc.
12.8M sh · $31.22M
Abrdn Plc
8.7M sh · $14.15M
Blackrock, Inc.
7.4M sh · $12.06M
Blackrock Inc.
6.8M sh · $21.05M
Vanguard Group Inc
4.9M sh · $8.05M
Nantahala Capital Management, LLC
4.1M sh · $6.72M
Millennium Management LLC
4.1M sh · $9.92M
Telemark Asset Management, LLC
4.0M sh · $9.76M
Ameriprise Financial Inc
3.8M sh · $6.18M
Prescott Group Capital Management, L.L.C.
2.6M sh · $4.19M
Ubs Group AG
2.2M sh · $3.56M
Geode Capital Management, LLC
2.0M sh · $3.3M

RATINGS SNAPSHOT

Overall rating: D+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Lamar Smith
Lamar Smith
Purchase
2018-04-06

INSIDER TRADES

★
DIRECTOR
Smith David V
Purchase · 66.3K shares
2026-06-17
★
DIRECTOR
De Vre Raymond
Purchase · 66.3K shares
2026-06-17
★
DIRECTOR
Singhvi Rahul
Purchase · 66.3K shares
2026-06-17
★
DIRECTOR
Martinborough Esther
Purchase · 66.3K shares
2026-06-17

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OVERWEIGHT 1
1 GRADES IN THE LAST 12 MONTHS
Piper Sandler OVERWEIGHT

SECTORS PEERS

PEERPRICE
OABI$4.47COMPARE
CCCC$3.85COMPARE
IVVD$0.96COMPARE
TARA$3.82COMPARE
IPHA$2.22COMPARE
IMDX$4.13COMPARE
RANI$0.84COMPARE